Top

Reactions Weekly

Published in:

01-11-2021 | Adalimumab | Case report

Adalimumab/metformin

Lack of efficacy: case report

Published in: Reactions Weekly | Issue 1/2021

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Costanzo G, et al. Two birds one stone: Semaglutide is highly effective against severe psoriasis in a type 2 diabetic patient. Endocrinology, Diabetes and Metabolism Case Reports 2021: No. 1, Jan 2021. Available from: URL: http://doi.org/10.1530/EDM-21-0007

Title: Adalimumab/metformin
Lack of efficacy: case report
Publication date: 01-11-2021
Publisher: Springer International Publishing
Keywords: Adalimumab
Metformin
Vulgar Psoriasis
Diabetes
Semaglutide
Type 2 Diabetes
Lifestyle Modifications
Published in: Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-021-04853-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Adalimumab/metformin

Lack of efficacy: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

Fenoldopam/prednisone

Alemtuzumab/tacrolimus

Methotrexate overdose

Multiple drugs

Methotrexate

Antibacterials/antituberculars